600267 logo

Zhejiang Hisun Pharmaceutical Co., Ltd. Stock Price

SHSE:600267 Community·CN¥12.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600267 Share Price Performance

CN¥10.53
2.16 (25.81%)
CN¥10.53
2.16 (25.81%)
Price CN¥10.53

600267 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet, good value and pays a dividend.

1 Risk
3 Rewards

Zhejiang Hisun Pharmaceutical Co., Ltd. Key Details

CN¥9.8b

Revenue

CN¥5.4b

Cost of Revenue

CN¥4.5b

Gross Profit

CN¥3.9b

Other Expenses

CN¥546.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 08, 2026
0.47
45.40%
5.56%
38.4%
View Full Analysis

About 600267

Founded
1956
Employees
7994
CEO
Weihong Xiao
WebsiteView website
www.hisunpharm.com

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is based in Taizhou, China.

Recent 600267 News & Updates

Recent updates

No updates